CEREBRAL TOXOPLASMOSIS side effect
What is CEREBRAL TOXOPLASMOSIS ?Drugs associated with CEREBRAL TOXOPLASMOSIS
AMBISOME CRIXIVAN CYCLOPHOSPHAMIDE CYCLOSPORINE FOSCAVIR KALETRA MABTHERA METHOTREXATE METHYLPREDNISOLO PREDNISONE RITUXIMAB SAQUINAVIR VALIXA ZIDOVUDINECEREBRAL TOXOPLASMOSIS : Mabthera Side Effects Report #5622380-1
Physician from FRANCE reported MABTHERA problem on Jan 29, 2008. Female patient, 52 years of age, was diagnosed with systemic lupus erythematosus, glomerulonephritis, renal failure and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: cerebral toxoplasmosis, . MABTHERA dosage: unknown. During the same period patient was treated with CELLCEPT, CORTANCYL, ENDOXAN. Patient was hospitalized and became disabled. Patient recovered.
CEREBRAL TOXOPLASMOSIS : Rituximab Side Effects Report #5580923-0
RITUXIMAB problem was reported by a Physician from UNITED KINGDOM on Dec 21, 2007. Male patient was diagnosed with chronic lymphocytic leukaemia, hypertension and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: cerebral toxoplasmosis, . RITUXIMAB dosage: 500 MG/M2, 1/MONTH. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, BISOPROLOL. Patient was hospitalized. Patient recovered.
CEREBRAL TOXOPLASMOSIS : Mabthera Side Effects Report #5594000-6
Physician from FRANCE reported MABTHERA problem on Jan 16, 2008. Female patient was diagnosed with systemic lupus erythematosus and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: cerebral toxoplasmosis, . MABTHERA dosage: unknown. During the same period patient was treated with CELLCEPT. Patient recovered.
CEREBRAL TOXOPLASMOSIS : Rituximab Side Effects Report #5595983-0
RITUXIMAB problem was reported by a Physician from UNITED KINGDOM on Jan 08, 2007. Male patient was diagnosed with chronic lymphocytic leukaemia, hypertension and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: cerebral toxoplasmosis, . RITUXIMAB dosage: 500 MG/M2, 1/MONTH. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE, BISOPROLOL FUMARATE. Patient was hospitalized. Patient recovered.
CEREBRAL TOXOPLASMOSIS : Mabthera Side Effects Report #5598911-7
Physician from FRANCE reported MABTHERA problem on Jan 07, 2008. Female patient was diagnosed with systemic lupus erythematosus and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: cerebral toxoplasmosis, . MABTHERA dosage: unknown. During the same period patient was treated with CELLCEPT, CORTANCYL, CYCLOPHOSPHAMIDE. Patient was hospitalized and became disabled. Patient recovered.
CEREBRAL TOXOPLASMOSIS : Prednisone Side Effects Report #5507311-7
PREDNISONE problem was reported by a Physician from JAPAN on Oct 19, 2007. Female patient, 54 years of age, was diagnosed with graft versus host disease and was treated with PREDNISONE. After drug was administered, patient experienced the following problems/side effects: cerebral toxoplasmosis, encephalitis, pneumonia bacterial, pseudomonal sepsis, therapeutic response decreased, . PREDNISONE dosage: 2 MG/KG; 0.2 MG/KG. During the same period patient was treated with ORAPRED, CYCLOPHOSPHAMIDE, CYCLOSPORINE, METHOTREXATE, TRIMETHOPRIM, SULFAMETHOXAZOLE, IMATINIB. Patient died.
CEREBRAL TOXOPLASMOSIS : Cyclophosphamide Side Effects Report #5519374-3
Health Professional from JAPAN reported CYCLOPHOSPHAMIDE problem on Nov 12, 2007. Male patient, 52 years of age, was diagnosed with bone marrow conditioning regimen, graft versus host disease and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: cerebral toxoplasmosis, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with METHOTREXATE, PREDNISOLONE, TACROLIMUS, MYCOPHENOLATE MOFETIL. Patient recovered.
CEREBRAL TOXOPLASMOSIS : Cyclophosphamide Side Effects Report #5519398-6
CYCLOPHOSPHAMIDE problem was reported by a Health Professional from JAPAN on Nov 12, 2007. Female patient, 54 years of age, was diagnosed with bone marrow conditioning regimen, prophylaxis against graft versus host disease and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: cerebral toxoplasmosis, pneumonia, sepsis, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOSPORINE, PREDNISOLONE, COTRIM, CLINDAMYCIN. Patient died.
CEREBRAL TOXOPLASMOSIS : Prednisone Side Effects Report #5484849-2
Physician from JAPAN reported PREDNISONE problem on Sept 25, 2007. Female patient, 24 years of age, was diagnosed with systemic lupus erythematosus and was treated with PREDNISONE. After drug was administered, patient experienced the following problems/side effects: cerebral toxoplasmosis, hemianopia homonymous, hemiparesis, loss of consciousness, . PREDNISONE dosage: 60 MG/QD; 12.5 MG/QD; 40 MG/QD;. During the same period patient was treated with ORAPRED. Patient was hospitalized. Patient recovered.
CEREBRAL TOXOPLASMOSIS : Rituximab Side Effects Report #5489426-5
RITUXIMAB problem was reported by a Physician from UNITED KINGDOM on Oct 09, 2007. Male patient was diagnosed with chronic lymphocytic leukaemia, hypertension and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: cerebral toxoplasmosis, . RITUXIMAB dosage: 500 MG/M2, 1/MONTH. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, BISOPROLOL FUMARATE. Patient was hospitalized. Patient recovered.
CEREBRAL TOXOPLASMOSIS : Mabthera Side Effects Report #5501066-8
Physician from FRANCE reported MABTHERA problem on Oct 19, 2007. Female patient was diagnosed with systemic lupus erythematosus and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: cerebral toxoplasmosis, . MABTHERA dosage: unknown. During the same period patient was treated with CELLCEPT. Patient recovered.
CEREBRAL TOXOPLASMOSIS : Methylprednisolo Side Effects Report #5501294-1
METHYLPREDNISOLONE SUCCINATE problem was reported by a Consumer or non-health professional from JAPAN on Oct 18, 2007. Male patient, 52 years of age, was diagnosed with histiocytosis haematophagic, graft versus host disease and was treated with METHYLPREDNISOLONE SUCCINATE. After drug was administered, patient experienced the following problems/side effects: cerebral toxoplasmosis, . METHYLPREDNISOLONE SUCCINATE dosage: unknown. During the same period patient was treated with METHYLPREDNISOLONE SUCCINATE, MYCOPHENOLATE MOFETIL. Patient recovered.
CEREBRAL TOXOPLASMOSIS : Methylprednisolo Side Effects Report #5502496-0
Consumer or non-health professional from JAPAN reported METHYLPREDNISOLONE problem on Oct 18, 2007. Female patient, 54 years of age, was diagnosed with graft versus host disease and was treated with METHYLPREDNISOLONE. After drug was administered, patient experienced the following problems/side effects: cerebral toxoplasmosis, pneumonia bacterial, . METHYLPREDNISOLONE dosage: unknown. During the same period patient was treated with CYCLOSPORINE. Patient died.
CEREBRAL TOXOPLASMOSIS : Ambisome Side Effects Report #5467181-2
AMBISOME problem was reported by a Health Professional from SPAIN on Sept 04, 2007. Male patient, 64 years of age, was treated with AMBISOME. After drug was administered, patient experienced the following problems/side effects: cerebral toxoplasmosis, hepatotoxicity, . AMBISOME dosage: 300 MG. During the same period patient was treated with VORICONAZOLE. Patient died on 09/11/2005.
CEREBRAL TOXOPLASMOSIS : Saquinavir Side Effects Report #5429379-9
Consumer or non-health professional from UNITED STATES reported SAQUINAVIR problem on Aug 17, 2007. Female patient, 31 years of age, was treated with SAQUINAVIR. After drug was administered, patient experienced the following problems/side effects: cerebral toxoplasmosis, . SAQUINAVIR dosage: unknown. During the same period patient was treated with ANTIBIOTIC NOS. Patient recovered.
CEREBRAL TOXOPLASMOSIS : Saquinavir Side Effects Report #5429380-5
SAQUINAVIR problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 17, 2007. Female patient, 31 years of age, was treated with SAQUINAVIR. After drug was administered, patient experienced the following problems/side effects: cerebral toxoplasmosis, . SAQUINAVIR dosage: unknown. During the same period patient was treated with ANTIBIOTIC NOS. Patient recovered.
CEREBRAL TOXOPLASMOSIS : Kaletra Side Effects Report #5392478-4
Physician from ROMANIA reported KALETRA problem on July 12, 2007. Male patient, weighting 112.4 lb, was diagnosed with hiv infection, oropharyngeal candidiasis and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: cerebral toxoplasmosis, . KALETRA dosage: unknown. During the same period patient was treated with LAMIVUDINE, VORICONAZOLE. Patient was hospitalized. Patient died on 04/29/2007.
CEREBRAL TOXOPLASMOSIS : Kaletra Side Effects Report #5392478-4
KALETRA problem was reported by a Physician from ROMANIA on July 12, 2007. Male patient, weighting 112.4 lb, was diagnosed with hiv infection, oropharyngeal candidiasis and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: cerebral toxoplasmosis, . KALETRA dosage: unknown. During the same period patient was treated with LAMIVUDINE, VORICONAZOLE. Patient was hospitalized. Patient died on 04/29/2007.
CEREBRAL TOXOPLASMOSIS : Cyclosporine Side Effects Report #5576127-8
Health Professional from GERMANY reported CYCLOSPORINE problem on Dec 19, 2007. Female patient, 56 years of age, was diagnosed with stem cell transplant, central nervous system leukaemia and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: cerebellar syndrome, cerebral toxoplasmosis, clonic convulsion, diplopia, electroencephalogram abnormal, extraocular muscle paresis, eyelid ptosis, gait disturbance, hemiplegia, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with METHOTREXATE, CYTARABINE, MYCOPHENOLATE MOFETIL, POSACONAZOLE, ACYCLOVIR, SULFAMETHOXAZOLE AND TRIMETHOPRIM, PENTAMIDINE ISETHIONATE. Patient was hospitalized. Patient recovered.
CEREBRAL TOXOPLASMOSIS : Prednisone Side Effects Report #5507314-2
PREDNISONE problem was reported by a Physician from JAPAN on Oct 19, 2007. Male patient, 52 years of age, was diagnosed with prophylaxis against graft versus host disease and was treated with PREDNISONE. After drug was administered, patient experienced the following problems/side effects: amnesia, cerebral toxoplasmosis, coma, diarrhoea, disease progression, disorientation, graft versus host disease, somnolence, . PREDNISONE dosage: 2 MG/KG; QD; 0.2 MG/KG; QD. During the same period patient was treated with ORAPRED, TRIMETHOPRIM, SULFAMETHOXAZOLE, METHOTREXATE, CYCLOPHOSPHAMIDE, TACROLIMUS, MYCOPHENOLATE MOFETIL. Patient recovered.
CEREBRAL TOXOPLASMOSIS : Crixivan Side Effects Report #5518806-4
Physician from JAPAN reported CRIXIVAN problem on Apr 17, 2007. Male patient, 45 years of age, weighting 123.5 lb, was diagnosed with hiv infection, cerebral toxoplasmosis, brain oedema and was treated with CRIXIVAN. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, cerebral toxoplasmosis, disseminated intravascular coagulation, histoplasmosis disseminated, pancytopenia, pneumonia, pyrexia, renal failure acute, . CRIXIVAN dosage: unknown. During the same period patient was treated with RETROVIR, EPIVIR, DARAPRIM, CLINDAMYCIN HYDROCHLORIDE, DALACIN S, HYDROCORTONE, PREDONINE. Patient was hospitalized. Patient died on 11/05/2001.
CEREBRAL TOXOPLASMOSIS : Crixivan Side Effects Report #5519475-X
CRIXIVAN problem was reported by a Health Professional from JAPAN on Apr 17, 2007. Male patient, 45 years of age, weighting 123.5 lb, was treated with CRIXIVAN. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, cerebral toxoplasmosis, disseminated intravascular coagulation, histoplasmosis disseminated, pancytopenia, pneumonia, pyrexia, renal failure acute, . CRIXIVAN dosage: unknown. During the same period patient was treated with PYRIMETHAMINE, CLINDAMYCIN, ZIDOVUDINE, LAMIVUDINE. Patient was hospitalized. Patient died on 11/05/2001.
CEREBRAL TOXOPLASMOSIS : Methotrexate Side Effects Report #5525450-1
Physician from JAPAN reported METHOTREXATE problem on Nov 06, 2007. Female patient, 54 years of age, was diagnosed with prophylaxis against graft versus host disease, acute graft versus host disease, chronic myeloid leukaemia and was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in liver, cerebral toxoplasmosis, chronic myeloid leukaemia, leukaemia recurrent, pneumonia bacterial, sepsis, . METHOTREXATE dosage: unknown. During the same period patient was treated with PREDNISOLONE, CYCLOPHOSPHAMIDE, IMATINIB, TRIMETHOPRIM, SULFAMETHOXAZOLE. Patient died.
CEREBRAL TOXOPLASMOSIS : Foscavir Side Effects Report #5463392-0
FOSCAVIR problem was reported by a Physician from JAPAN on Aug 27, 2007. Male patient was diagnosed with infection prophylaxis, hiv infection and was treated with FOSCAVIR. After drug was administered, patient experienced the following problems/side effects: acute respiratory failure, cerebral toxoplasmosis, disseminated intravascular coagulation, eating disorder, encephalitis, loss of consciousness, pancytopenia, pleural adhesion, pneumothorax, . FOSCAVIR dosage: unknown. During the same period patient was treated with COMBIVIR, KALETRA, REYATAZ, EPZICOM, ZITHROMAC, VALGANCICLOVIR. Patient was hospitalized. Patient recovered.
CEREBRAL TOXOPLASMOSIS : Valixa Side Effects Report #5464349-6
Physician from JAPAN reported VALIXA problem on Sept 11, 2007. Male patient, 49 years of age, was diagnosed with encephalitis cytomegalovirus, hiv infection and was treated with VALIXA. After drug was administered, patient experienced the following problems/side effects: acute respiratory failure, cerebral toxoplasmosis, disseminated intravascular coagulation, eating disorder, encephalitis, loss of consciousness, pancytopenia, pneumothorax, respiratory arrest, . VALIXA dosage: unknown. During the same period patient was treated with COMBIVIR, KALETRA, FOSCAVIR, EPZICOM, REYATAZ. Patient was hospitalized. Patient recovered.
CEREBRAL TOXOPLASMOSIS : Zidovudine Side Effects Report #5421796-6
ZIDOVUDINE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 06, 2007. Male patient, 43 years of age, was diagnosed with hiv infection and was treated with ZIDOVUDINE. After drug was administered, patient experienced the following problems/side effects: bk virus infection, cerebral toxoplasmosis, encephalitis, . ZIDOVUDINE dosage: unknown. During the same period patient was treated with LAMIVUDINE, EFAVIRENZ, COMBIVIR, FLUCONAZOLE, COTRIM, ISONIAZID. Patient was hospitalized. Patient recovered.
CEREBRAL TOXOPLASMOSIS : Kaletra Side Effects Report #5612965-0
Physician from JAPAN reported KALETRA problem on Jan 25, 2008. Male patient was diagnosed with hiv infection, antifungal prophylaxis, toxoplasmosis, prophylaxis against gastrointestinal ulcer and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: blood alkaline phosphatase increased, blood amylase increased, cerebral toxoplasmosis, hyperlipidaemia, immune reconstitution syndrome, . KALETRA dosage: unknown. During the same period patient was treated with LAMIVUDINE, STAVUDINE, ABACAVIR SULPHATE, BACTRIM, ATOVAQUONE, OMEPRAZOLE. Patient recovered.
CEREBRAL TOXOPLASMOSIS : Cyclosporine Side Effects Report #5486276-0
CYCLOSPORINE problem was reported by a Consumer or non-health professional from JAPAN on Oct 10, 2007. Female patient, 54 years of age, was diagnosed with stem cell transplant, acute graft versus host disease in liver and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: blast crisis in myelogenous leukaemia, cd4 lymphocytes decreased, cerebral toxoplasmosis, csf protein increased, csf white blood cell count increased, headache, nuchal rigidity, pneumonia bacterial, pseudomonal sepsis, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with PREDNISOLONE, SULFAMETHOXAZOLE W. Patient died.
CEREBRAL TOXOPLASMOSIS : Cyclosporine Side Effects Report #5494605-7
Health Professional from JAPAN reported CYCLOSPORINE problem on Oct 22, 2007. Female patient, 54 years of age, was diagnosed with stem cell transplant, acute graft versus host disease in liver and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: blast crisis in myelogenous leukaemia, cd4 lymphocytes decreased, cerebral toxoplasmosis, csf protein increased, csf white blood cell count increased, headache, nuchal rigidity, pneumonia bacterial, pseudomonal sepsis, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with PREDNISOLONE, SULFAMETHOXAZOLE AND TRIMETHOPRIM. Patient died.
CEREBRAL TOXOPLASMOSIS : Cyclosporine Side Effects Report #5411970-7
CYCLOSPORINE problem was reported by a Health Professional from JAPAN on Aug 07, 2007. Female patient, 54 years of age, was diagnosed with stem cell transplant, acute graft versus host disease in liver and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: blast crisis in myelogenous leukaemia, cd4 lymphocytes decreased, cerebral toxoplasmosis, csf protein increased, csf white blood cell count increased, headache, nuchal rigidity, pneumonia bacterial, pseudomonal sepsis, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with PREDNISOLONE, SULFAMETHOXAZOLE W. Patient died.
CEREBRAL TOXOPLASMOSIS : Cyclosporine Side Effects Report #5412282-8
Health Professional from JAPAN reported CYCLOSPORINE problem on Aug 07, 2007. Female patient, 54 years of age, was diagnosed with stem cell transplant, acute graft versus host disease in liver and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: blast crisis in myelogenous leukaemia, cd4 lymphocytes decreased, cerebral toxoplasmosis, csf protein increased, csf white blood cell count increased, headache, nuchal rigidity, pneumonia bacterial, pseudomonal sepsis, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with PREDNISOLONE, SULFAMETHOXAZOLE W. Patient died.